References
1. Wang SY, Luo J, Dong YF, et al. Risk of glomerular filtration rate
decline in patients with hypertrophic cardiomyopathy and obstructive
sleep apnoea. Sci Rep. 2017;7(1):17399.
2. Rowin EJ, Hausvater A, Link MS, et al. Clinical Profile and
Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.Circulation. 2017;136(25):2420-2436.
3. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ.
Impact of atrial fibrillation on the clinical course of hypertrophic
cardiomyopathy. Circulation. 2001;104(21):2517-2524.
4. Maron BJ, Olivotto I, Bellone P, et al. Clinical profile of stroke in
900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol.2002;39(2):301-307.
5. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a
predictor of outcome in a broad spectrum of patients with heart failure.Circulation. 2006;113(5):671-678.
6. Verma A, Anavekar NS, Meris A, et al. The relationship between renal
function and cardiac structure, function, and prognosis after myocardial
infarction: the VALIANT Echo Study. J Am Coll Cardiol.2007;50(13):1238-1245.
7. Ronco C, Di Lullo L. Cardiorenal syndrome. Heart Fail Clin.2014;10(2):251-280.
8. Park JW, Yang PS, Bae HJ, et al. Five-Year Change in the Renal
Function After Catheter Ablation of Atrial Fibrillation. J Am
Heart Assoc. 2019;8(17):e013204.
9. Huang FY, Zhang JL, Huang BT, Peng Y, Chen SJ, Chen M. Renal function
as a predictor of outcomes in patients with hypertrophic cardiomyopathy:
A cohort study of a hospitalized population. Clin Chim Acta.2021;512:92-99.
10. Takahashi Y, Takahashi A, Kuwahara T, et al. Renal function after
catheter ablation of atrial fibrillation. Circulation.2011;124(22):2380-2387.
11. Deng H, Shantsila A, Xue Y, et al. Renal function and outcomes after
catheter ablation of patients with atrial fibrillation: The Guangzhou
atrial fibrillation ablation registry. Arch Cardiovasc Dis.2019;112(6-7):420-429.
12. Benedetto U, Head SJ, Angelini GD, Blackstone EH. Statistical
primer: propensity score matching and its alternatives. Eur J
Cardiothorac Surg. 2018;53(6):1112-1117.
13. Deb S, Austin PC, Tu JV, et al. A Review of Propensity-Score Methods
and Their Use in Cardiovascular Research. Can J Cardiol.2016;32(2):259-265.
14. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated
GFR from serum creatinine in Japan. Am J Kidney Dis.2009;53(6):982-992.
15. Maron BJ. Hypertrophic cardiomyopathy: a systematic review.JAMA. 2002;287(10):1308-1320.
16. Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation
pathophysiology: implications for management. Circulation.2011;124(20):2264-2274.
17. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close
bidirectional relationship between chronic kidney disease and atrial
fibrillation: the Niigata preventive medicine study. Am Heart J.2009;158(4):629-636.
18. Genovesi S, Pogliani D, Faini A, et al. Prevalence of atrial
fibrillation and associated factors in a population of long-term
hemodialysis patients. Am J Kidney Dis. 2005;46(5):897-902.
19. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a
risk factor for atrial fibrillation. Circulation.2003;108(24):3006-3010.
20. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA.
Independent risk factors for atrial fibrillation in a population-based
cohort. The Framingham Heart Study. JAMA. 1994;271(11):840-844.
21. Navaravong L, Barakat M, Burgon N, et al. Improvement in estimated
glomerular filtration rate in patients with chronic kidney disease
undergoing catheter ablation for atrial fibrillation. J Cardiovasc
Electrophysiol. 2015;26(1):21-27.
22. Machino-Ohtsuka T, Seo Y, Ishizu T, et al. Significant improvement
of left atrial and left atrial appendage function after catheter
ablation for persistent atrial fibrillation. Circ J.2013;77(7):1695-1704.
23. Muellerleile K, Groth M, Steven D, et al. Cardiovascular magnetic
resonance demonstrates reversible atrial dysfunction after catheter
ablation of persistent atrial fibrillation. J Cardiovasc
Electrophysiol. 2013;24(7):762-767.
24. Freed BH, Daruwalla V, Cheng JY, et al. Prognostic Utility and
Clinical Significance of Cardiac Mechanics in Heart Failure With
Preserved Ejection Fraction: Importance of Left Atrial Strain.Circ Cardiovasc Imaging. 2016;9(3).
25. Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions:
insights from the ESCAPE trial. J Am Coll Cardiol.2008;51(13):1268-1274.
26. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ,
Hillege HL. Increased central venous pressure is associated with
impaired renal function and mortality in a broad spectrum of patients
with cardiovascular disease. J Am Coll Cardiol.2009;53(7):582-588.
27. Sohns C, Zintl K, Zhao Y, et al. Impact of Left Ventricular Function
and Heart Failure Symptoms on Outcomes Post Ablation of Atrial
Fibrillation in Heart Failure: CASTLE-AF Trial. Circ Arrhythm
Electrophysiol. 2020;13(10):e008461.
28. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L.
Predictors of primary atrial fibrillation and concomitant clinical and
hemodynamic changes in patients with chronic heart failure: a
prospective study in 344 patients with baseline sinus rhythm. J Am
Coll Cardiol. 1998;32(1):197-204.
29. Providencia R, Elliott P, Patel K, et al. Catheter ablation for
atrial fibrillation in hypertrophic cardiomyopathy: a systematic review
and meta-analysis. Heart. 2016;102(19):1533-1543.
30. Dinshaw L, Munkler P, Schaffer B, et al. Ablation of Atrial
Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment
Strategy, Characteristics of Consecutive Atrial Tachycardia and
Long-Term Outcome. J Am Heart Assoc. 2021;10(3):e017451.
31. Santangeli P, Di Biase L, Themistoclakis S, et al. Catheter ablation
of atrial fibrillation in hypertrophic cardiomyopathy: long-term
outcomes and mechanisms of arrhythmia recurrence. Circ Arrhythm
Electrophysiol. 2013;6(6):1089-1094.
32. Della Rocca DG, Tarantino N, Trivedi C, et al. Non-pulmonary vein
triggers in nonparoxysmal atrial fibrillation: Implications of
pathophysiology for catheter ablation. J Cardiovasc
Electrophysiol. 2020;31(8):2154-2167.
33. Zhao Y, Zhang J, Wang X. Catheter ablation of extra-pulmonary vein
foci improves the clinical outcome in patients with paroxysmal atrial
fibrillation. Int J Cardiol. 2014;172(2):458-459.